Search Results - "FEDGCHIN, Margaret"

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients by NYGREN, Peter, HANDE, Kenneth, GOTTESDIENER, Keith M, COCQUYT, Veronique, VAN BELLE, Simon, PETTY, Kevin J, FEDGCHIN, Margaret, VAN DYCK, Kristien, MAJUMDAR, Anup, PANEBIANCO, Debbie, DE SMET, Marina, AHMED, Tuli, MURPHY, M. Gail

“…Aprepitant is a selective neurokinin-1 receptor antagonist that is effective for the prevention of nausea and vomiting caused by highly emetogenic…”
Get full text

Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial by Wang, Hao, Romano, Gary, Frustaci, Mary Ellen, Bohidar, Norm, Ma, Huizhong, Sanga, Panna, Ness, Seth, Russell, Lucille J, Fedgchin, Margaret, Kelly, Kathleen M, Thipphawong, John

“…OBJECTIVE:To assess efficacy and safety of fulranumab, a fully human monoclonal antibody against nerve growth factor, in patients with diabetic peripheral…”
Get full text

Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study by Wang, Hao, Romano, Gary, Fedgchin, Margaret, Russell, Lucille, Sanga, Panna, Kelly, Kathleen M, Frustaci, Mary Ellen, Thipphawong, John

“…OBJECTIVE:Fulranumab is an antibody that specifically neutralizes the biological activity of human nerve growth factor. This multicenter, phase-2, randomized,…”
Get full text

Analgesic Efficacy of Fulranumab in Patients with Painful Diabetic Peripheral Neuropathy in a Randomized, Placebo-Controlled, Double-Blind Study (S58.002) by Wang, Hao, Romano, Gary, Frustaci, Mary Ellen, Sanga, Panna, Ness, Seth, Russell, Lucille, Fedgchin, Margaret, Kelly, Kathleen, Thipphawong, John

“…Abstract only…”
Get full text

Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant by Stoch, S. Aubrey, Gargano, Cynthia, Valentine, Jack, Braun, Matthew P., Murphy, M. Gail, Fedgchin, Margaret, Majumdar, Anup, Pequignot, Edward, Gottesdiener, Keith M., Petty, Kevin J., Panebianco, Deborah, Dean, Dennis, Kraft, Walter K., Greenberg, Howard E.

“…Purpose Because glucocorticoids and the neurokinin-1 receptor antagonist aprepitant influence CYP3A4 activity, this study assessed whether aprepitant added to…”
Get full text